Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
321 participants
OBSERVATIONAL
2024-07-09
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary objectives of the EMERGE Mothers and Kids follow up study are:
1. to determine whether treatment with metformin leads to a reduction in maternal disorders of glucose, metabolic syndrome, obesity, hypertension and lipids at up to 10 years post the index pregnancy;
2. to examine the impact of metformin on maternal anxiety, depression, quality of life and breast feeding duration;
3. to examine whether exposure to metformin leads to a reduction in obesity in the offspring at follow up;
4. to determine whether treatment with metformin during pregnancy, in women with GDM, leads to a reduction in adiposity in the offspring at follow up as measured by anthropometric measurements and sum of skinfolds.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MiTy Kids (Metformin in Women With Type 2 Diabetes in Pregnancy Kids Trial)
NCT01832181
Metformin Versus Insulin in the Treatment of Gestational Diabetes Mellitus
NCT01087866
Comparison Between Metformin and Glyburide in the Management of Gestational Diabetes
NCT06589141
Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose Tolerance
NCT00667498
Metformin in Women With Type 2 Diabetes in Pregnancy Trial
NCT01353391
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention as the study is observational.
No intervention as the study is observational.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National University of Ireland, Galway, Ireland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fidelma Dunne
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Galway
Galway, , Ireland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Prof. Fidelma Dunne
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-CRFG-21
Identifier Type: OTHER
Identifier Source: secondary_id
23-CRFG-21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.